WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center forContinue Reading
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The U.S. Food and Drug Administration is poised to approve Pfizer’s COVID booster shots for all American adults as early as Thursday. That would make tens of millions more Americans eligible for the booster doses, sources familiar with the plan told The NewContinue Reading
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The Biden administration plans to invest billions to partner with industry to expand the nation’s ability to produce coronavirus vaccines, ensure domestic supply and help poor nations in their vaccination efforts. The goal of the plan, to be announced Wednesday, is to produceContinue Reading
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — Nearly 1 in 3 older Americans plan an extended trip next year, and 1 in 4 plan to travel for the holidays, but many will take COVID-19 into account, a new survey shows. If COVID cases surge at their destination, 20% said theyContinue Reading
TUESDAY, Nov. 16, 2021 (HealthDay News) — Pfizer announced Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its new antiviral pill in people at high risk for severe COVID-19. “With more than 5 million deaths and countless lives impacted by thisContinue Reading
TUESDAY, Nov. 16, 2021 (HealthDay News) — For decades, doctors have struggled with the fact that the benefit of any blood-thinning pill came with the added risk of excess bleeding. Now, an experimental anti-clotting pill called milvexian has been found to be effective in patients who had knee replacement surgeryContinue Reading
TUESDAY, Nov. 16, 2021 (HealthDay News) — A rare inflammatory condition associated with COVID-19 in children was more severe in the second wave of patients than in the first, researchers report. For the study, investigators examined the cases of 106 patients with multisystem inflammatory syndrome in children (MIS-C) who arrivedContinue Reading
MONDAY, Nov. 15, 2021 (HealthDay News) — Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates. Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for the treatment of depression. They include drugs likeContinue Reading
MONDAY, Nov. 15, 2021 (HealthDay News) — A new and expensive Alzheimer’s drug called Aduhelm is responsible for about half of the $21.60 increase in monthly premiums for Medicare’s Part B outpatient program in 2022, Medicare officials report. The new premium will be $170.10 a month, and the $21.60 boostContinue Reading
MONDAY, Nov. 15, 2021 (HealthDay News) — For Emily Litvin, this Thanksgiving is going to look different from the last one and she couldn’t be happier about it. “I’m so excited to have some sort of normalcy, especially for my daughter and her cousins. It’s nice for them to allContinue Reading